TAYSHA GENE THERAPIES INC (TSHA)
Sector: Health Care
Sector: Health Care
Compensation data for top executives (showing up to 3 years of data)
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Sean Nolan Chief Executive Officer and Director | 2025 | $645,840 | $0 | $1,651,125 | $1,258,425 | $542,506 | $1,169 | $4,099,065 |
| 2024 | $621,000 | $0 | $2,025,816 | $1,670,410 | $409,860 | $774 | $4,727,861 | |
| 2023 | $600,000 | $0 | $0 | $597,184 | $324,000 | $1,331 | $1,522,515 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Kamran Alam Chief Financial Officer | 2025 | $473,331 | $0 | $797,350 | $607,710 | $265,066 | $3,507 | $2,146,964 |
| 2024 | $455,126 | $0 | $1,009,606 | $832,482 | $210,942 | $10,620 | $2,518,777 | |
| 2023 | $413,751 | $0 | $0 | $402,039 | $148,950 | $10,661 | $975,401 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Sukumar Nagendran, M.D. President and Head of Research and Development and Director | 2025 | $608,166 | $0 | $600,325 | $457,545 | $425,716 | $1,138 | $2,092,890 |
| 2024 | $584,775 | $0 | $1,476,785 | $1,217,700 | $321,626 | $774 | $3,601,660 | |
| 2023 | $565,000 | $0 | $0 | $427,526 | $254,250 | $1,344 | $1,248,120 |